MedDataX Logo

Effect of Osteopathic Lymphatic Treatment on Plasma Volume, Protein Concentration and Albumin Concentration.

NCT ID: NCT00742989

Last Updated: 2008-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-31

Study Completion Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project is to see how much an osteopathic lymphatic treatment (OLT) causes an increase in plasma volume, total plasma protein concentration, and albumin concentration. This is an important step in understanding the effects of OLT, specifically its effects on fluid in the body. The primary role of the lymph system is the return of fluid and proteins lost from the blood vessels. Despite this, no research has been done to see what effects an OLT has on fluid and protein levels in the blood.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

osteopathic lymphatic treatment OLT normal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

OLT administration

Group Type EXPERIMENTAL

OLT maneuver

Intervention Type OTHER

direct myofascial release for the thoracic inlet for 30 seconds, supine rib raising for 1 minute on each side of the body, thoracic pumping for one minute, thoracic vacuum for 30 seconds, doming of the abdominal diaphragm for 30 seconds, abdominal pumping for 1 minute, pedal pumping for 1 minute, a second thoracic pump for 1 minute, a second thoracic vacuum for 30 seconds, and a final direct myofascial release for the thoracic inlet lasting 30 seconds

B

placebo-OLT

Group Type SHAM_COMPARATOR

Sham OLT

Intervention Type OTHER

Therapeutic massage performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OLT maneuver

direct myofascial release for the thoracic inlet for 30 seconds, supine rib raising for 1 minute on each side of the body, thoracic pumping for one minute, thoracic vacuum for 30 seconds, doming of the abdominal diaphragm for 30 seconds, abdominal pumping for 1 minute, pedal pumping for 1 minute, a second thoracic pump for 1 minute, a second thoracic vacuum for 30 seconds, and a final direct myofascial release for the thoracic inlet lasting 30 seconds

Intervention Type OTHER

Sham OLT

Therapeutic massage performed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal, healthy volunteers
* Males
* Age 20 to 40 years

Exclusion Criteria

* History of cardiovascular, kidney, or liver disease.
* Cannot have taken medication or drugs or have been ill at the time of the study or for two weeks prior.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kansas City University of Medicine and Biosciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kansas City University of Medicine and Biosciences

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

W. Evan Rivers, DO

Role: PRINCIPAL_INVESTIGATOR

Kansas City University of Medicine and Biosciences

Charlott L. Williiams, RN, CCRC

Role: STUDY_DIRECTOR

Kansas City University of Medicine and Biosciences

Alan G. Glaros, PhD

Role: STUDY_DIRECTOR

KCUMB

Kevin Treffer, DO

Role: STUDY_CHAIR

KCUMB

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences

Kansas City, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Rivers WE, Treffer KD, Glaros AG, Williams CL. Short-term hematologic and hemodynamic effects of osteopathic lymphatic techniques: a pilot crossover trial. J Am Osteopath Assoc. 2008 Nov;108(11):646-51.

Reference Type DERIVED
PMID: 19011227 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KCUMB-2005-01

Identifier Type: -

Identifier Source: org_study_id